Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7682613rdf:typepubmed:Citationlld:pubmed
pubmed-article:7682613lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:7682613lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:7682613lifeskim:mentionsumls-concept:C0027428lld:lifeskim
pubmed-article:7682613lifeskim:mentionsumls-concept:C0042401lld:lifeskim
pubmed-article:7682613lifeskim:mentionsumls-concept:C0075766lld:lifeskim
pubmed-article:7682613lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:7682613pubmed:issue1lld:pubmed
pubmed-article:7682613pubmed:dateCreated1993-5-18lld:pubmed
pubmed-article:7682613pubmed:abstractTextWe studied the role of different tachykinin receptors in mediating neurogenic vasodilation in the nasal mucosa of anesthetized pathogen-free rats. Three successive determinations of blood flow were made by injecting radionuclide-labeled microspheres suspended in 70% dextrose into the left ventricle. A selective agonist of the tachykinin NK1 receptor increased nasal blood flow, but neurokinin NK2- and NK3-selective agonists were without effect. The natural agonist of NK1 receptors, substance P (1 microgram/kg), increased nasal blood flow, an effect that was abolished by the selective NK1 receptor antagonist (+)-(2S,3S)-3-(2-methoxybenzylamino)-2-phenylpiperidine (CP-99,994). Capsaicin (25 micrograms/kg), a drug that releases tachykinins from sensory nerves, increased nasal blood flow, and this effect was significantly reduced by CP-99,994. We conclude that a significant component of neurogenic vasodilation in rat nasal mucosa is due to the stimulation of NK1 tachykinin receptors.lld:pubmed
pubmed-article:7682613pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682613pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682613pubmed:languageenglld:pubmed
pubmed-article:7682613pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682613pubmed:citationSubsetIMlld:pubmed
pubmed-article:7682613pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682613pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682613pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682613pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682613pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682613pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682613pubmed:statusMEDLINElld:pubmed
pubmed-article:7682613pubmed:monthAprlld:pubmed
pubmed-article:7682613pubmed:issn0022-3565lld:pubmed
pubmed-article:7682613pubmed:authorpubmed-author:PeterssonGGlld:pubmed
pubmed-article:7682613pubmed:authorpubmed-author:NadelJ AJAlld:pubmed
pubmed-article:7682613pubmed:authorpubmed-author:BertrandCClld:pubmed
pubmed-article:7682613pubmed:authorpubmed-author:HoffmanJ IJIlld:pubmed
pubmed-article:7682613pubmed:authorpubmed-author:SniderR MRMlld:pubmed
pubmed-article:7682613pubmed:authorpubmed-author:PiedimonteGGlld:pubmed
pubmed-article:7682613pubmed:authorpubmed-author:DesaiM CMClld:pubmed
pubmed-article:7682613pubmed:authorpubmed-author:HusseiniW KWKlld:pubmed
pubmed-article:7682613pubmed:issnTypePrintlld:pubmed
pubmed-article:7682613pubmed:volume265lld:pubmed
pubmed-article:7682613pubmed:ownerNLMlld:pubmed
pubmed-article:7682613pubmed:authorsCompleteYlld:pubmed
pubmed-article:7682613pubmed:pagination36-40lld:pubmed
pubmed-article:7682613pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7682613pubmed:meshHeadingpubmed-meshheading:7682613-...lld:pubmed
pubmed-article:7682613pubmed:meshHeadingpubmed-meshheading:7682613-...lld:pubmed
pubmed-article:7682613pubmed:meshHeadingpubmed-meshheading:7682613-...lld:pubmed
pubmed-article:7682613pubmed:meshHeadingpubmed-meshheading:7682613-...lld:pubmed
pubmed-article:7682613pubmed:meshHeadingpubmed-meshheading:7682613-...lld:pubmed
pubmed-article:7682613pubmed:meshHeadingpubmed-meshheading:7682613-...lld:pubmed
pubmed-article:7682613pubmed:meshHeadingpubmed-meshheading:7682613-...lld:pubmed
pubmed-article:7682613pubmed:meshHeadingpubmed-meshheading:7682613-...lld:pubmed
pubmed-article:7682613pubmed:meshHeadingpubmed-meshheading:7682613-...lld:pubmed
pubmed-article:7682613pubmed:meshHeadingpubmed-meshheading:7682613-...lld:pubmed
pubmed-article:7682613pubmed:meshHeadingpubmed-meshheading:7682613-...lld:pubmed
pubmed-article:7682613pubmed:meshHeadingpubmed-meshheading:7682613-...lld:pubmed
pubmed-article:7682613pubmed:meshHeadingpubmed-meshheading:7682613-...lld:pubmed
pubmed-article:7682613pubmed:year1993lld:pubmed
pubmed-article:7682613pubmed:articleTitleNeurogenic vasodilation in the rat nasal mucosa involves neurokinin1 tachykinin receptors.lld:pubmed
pubmed-article:7682613pubmed:affiliationCardiovascular Research Institute, University of California, San Francisco.lld:pubmed
pubmed-article:7682613pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7682613pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7682613pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed